A phase I study of accelerated high dose epirubicin (HDE) and cisplatin with G-CSF support in patients with advanced non small cell lung cancer (NSCLC)

被引：0
|
作者：
Smit, EF [1 ]
Postmus, PE [1 ]
机构：
[1] Vrije Univ Amsterdam, Acad Hosp, Dept Pulm Dis, Amsterdam, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OP143
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [31] RELATIONSHIP BETWEEN THE G-CSF AND BONE METABOLISM IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS
    Ohno, Yasushi
    Kamiya, Fumihiko
    Yanase, Koumei
    Ito, Fumitaka
    Mori, Hidenori
    Nishigaki, Kazuhiko
    Funaguchi, Norihiko
    Endo, Junki
    Iihara, Hirotoshi
    Aoyama, Takuma
    Minatoguchi, Shinya
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1197 - S1197
  • [32] Activity of high-dose epirubicin combined with gemcitabine in advanced non-small-cell lung cancer: a multicenter phase I and II study
    J W G van Putten
    P Eppinga
    Z Erjavec
    G de Leede
    J Nabers
    J B E Smeets
    D Th Sleijfer
    H J M Groen
    British Journal of Cancer, 2000, 82 : 806 - 811
  • [33] Activity of high-dose epirubicin combined with gemcitabine in advanced non-small-cell lung cancer: a multicenter phase I and II study
    van Putten, JWG
    Eppinga, P
    Erjavec, Z
    de Leede, G
    Nabers, J
    Smeets, JBE
    Sleijfer, DT
    Green, HJM
    BRITISH JOURNAL OF CANCER, 2000, 82 (04) : 806 - 811
  • [34] Phase II study of a closely spaced ifosfamide-cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanoma
    Planting, AST
    deWit, R
    vanderBurg, MEL
    Stoter, G
    Verweij, J
    ANNALS OF ONCOLOGY, 1996, 7 (10) : 1080 - 1082
  • [35] Phase II study of Gemcitabine, ifosfamide and cisplatin (GIP) in patients with advanced non-small cell lung cancer (NSCLC)
    De las Penas, R
    Busquier, I
    Munarriz, J
    Lopez, A
    Llorente, R
    Alberola, V
    Frau, A
    ANNALS OF ONCOLOGY, 1998, 9 : 88 - 88
  • [36] A phase I study of cisplatin ip and carboplatin iv with G-CSF in patients with ovarian cancer
    Adachi, S
    Ito, K
    Itani, Y
    Noda, T
    Shintani, M
    Kawai, S
    Beppu, K
    Ito, A
    Saito, K
    Hisanaga, H
    Fukumoto, Y
    Tomii, Y
    Masuda, M
    ONCOLOGY REPORTS, 1999, 6 (02) : 311 - 315
  • [37] Gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC): A phase II study
    Orlandi-Jorquera, L
    Orlandi, F
    Galaz, P
    Gamargo, C
    Salman, P
    Yanez, M
    ANNALS OF ONCOLOGY, 1998, 9 : 101 - 101
  • [38] Erlotinib in combination with pemetrexed for patients with advanced non-small-cell lung cancer (NSCLC): a phase I dose-finding study
    Ranson, M.
    Reck, M.
    Anthoney, A.
    Hanauske, A. -R
    Dean, E.
    Melezinek, I.
    Klingelschmitt, G.
    Kletzl, H.
    Blatter, J.
    Twelves, C.
    ANNALS OF ONCOLOGY, 2010, 21 (11) : 2233 - 2239
  • [39] G-CSF improves the safety of adjuvant chemotherapy with cisplatin and vinorelbine in resected non small cell lung cancer (NSCLC): closing the audit loop
    Chiramel, J.
    Alzoubi, M.
    Fisher, P. M.
    Woll, P. J.
    LUNG CANCER, 2013, 79 : S12 - S12
  • [40] Phase I study of hyperfractionated accelerated radiotherapy and escalating doses of daily cisplatin for patients with locally advanced non-small-cell lung cancer
    Schild, SE
    Wong, WW
    Vora, SA
    Halyard, MY
    Wheeler, RH
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (03): : 729 - 734
12345